|
US20020137890A1
(en)
*
|
1997-03-31 |
2002-09-26 |
Genentech, Inc. |
Secreted and transmembrane polypeptides and nucleic acids encoding the same
|
|
US20060160181A1
(en)
*
|
2000-02-15 |
2006-07-20 |
Amgen Inc. |
Fibroblast Growth Factor-23 molecules and uses thereof
|
|
WO2001066595A2
(en)
*
|
2000-03-08 |
2001-09-13 |
Chiron Corporation |
Human fgf-23 gene and gene expression products
|
|
CN101275136A
(zh)
*
|
2000-08-11 |
2008-10-01 |
麒麟医药株式会社 |
调节磷酸代谢,钙代谢,钙化和维生素d代谢的多肽及其编码dna
|
|
US6838264B2
(en)
|
2000-12-05 |
2005-01-04 |
Immutopics, Inc. |
Antibodies and peptide antigens for producing antibodies having a selective binding specificity to bioactive intact parathyroid hormone (PTH) 1-84
|
|
US7226749B2
(en)
|
2000-12-05 |
2007-06-05 |
Zahradnik Richard J |
Antibodies and peptide antigens for producing antibodies having a selective binding specificity to bioactive intact parathyroid hormone (PTH) 1-84
|
|
RU2003123108A
(ru)
*
|
2000-12-26 |
2005-02-27 |
Чугаи Сейяку Кабусики Кайся (Jp) |
Мутантные формы человеческого белка fgf23, снижающие содержание фосфора в крови
|
|
WO2002088358A2
(en)
*
|
2001-04-26 |
2002-11-07 |
Geneprot, Inc. |
Human fibroblast growth factor-related compositions
|
|
DE60329070D1
(de)
*
|
2001-12-28 |
2009-10-15 |
Kyowa Hakko Kirin Co Ltd |
Antikörper gegen den fibroblastenwachstumsfaktor 23
|
|
US7094551B2
(en)
|
2002-09-17 |
2006-08-22 |
Zahradnik Richard J |
Immunoassays, assay methods, antibodies and method of creating antibodies for detecting FGF-23
|
|
ATE507296T1
(de)
*
|
2003-11-07 |
2011-05-15 |
Novartis Ag |
Verwendung von fibroblasten-wachstumsfaktor- fragmenten
|
|
IL161886A0
(en)
*
|
2004-05-09 |
2005-11-20 |
Technion Res & Dev Foundation |
Development of inducers of udp-n-acetyl-alphad-galactosamine: polypeptide n-acetylgalactosami-nyltransferase 3(ppgantase
|
|
EP1745151B1
(en)
*
|
2004-05-09 |
2009-12-02 |
Technion Research And Development Foundation, Ltd. |
Methods relating to disorders associated with abnormal phosphate metabolism
|
|
MX2007013005A
(es)
*
|
2005-04-18 |
2008-01-16 |
Clearplay Inc |
Aparato, sistema y metodo para asociar uno o mas archivos de filtro con una presentacion multimedia particular.
|
|
KR100760525B1
(ko)
*
|
2006-04-13 |
2007-10-04 |
김재만 |
병원성 미생물의 무증폭 다중 정량 검출킷트 및 검출방법
|
|
US8012694B2
(en)
|
2006-09-14 |
2011-09-06 |
Immutopics, Inc. |
Assay for the detection of phosphorylated PTH
|
|
WO2008089936A1
(en)
*
|
2007-01-22 |
2008-07-31 |
Medizinische Universität Innsbruck |
Novel markers for chronic kidney disease
|
|
US7883705B2
(en)
*
|
2007-02-14 |
2011-02-08 |
Kyowa Hakko Kirin Co., Ltd. |
Anti FGF23 antibody and a pharmaceutical composition comprising the same
|
|
US20110183434A1
(en)
*
|
2008-01-17 |
2011-07-28 |
Myles Wolf |
Diagnostic methods and kits using fibroblast growth factor-23
|
|
US8420088B2
(en)
*
|
2008-01-28 |
2013-04-16 |
Novartis Ag |
Methods and compositions using FGF23 fusion polypeptides
|
|
TW200936156A
(en)
|
2008-01-28 |
2009-09-01 |
Novartis Ag |
Methods and compositions using Klotho-FGF fusion polypeptides
|
|
BRPI0911491A2
(pt)
*
|
2008-04-29 |
2016-01-05 |
Novartis Ag |
métodos de monitoramento da modulação de atividade de quinase de receptor de fator de crescimento de fibroblasto e usos dos ditos métodos.
|
|
US8889621B2
(en)
|
2009-10-30 |
2014-11-18 |
New York University |
Inhibiting binding of FGF23 to the binary FGFR-Klotho complex for the treatment of hypophosphatemia
|
|
US20110195077A1
(en)
|
2010-01-29 |
2011-08-11 |
Novartis Ag |
Methods and compositions using fgf23 fusion ppolypeptides
|
|
EP3985393B1
(en)
|
2010-08-31 |
2023-10-04 |
Minaris Medical Co., Ltd. |
Method for measuring fibroblast growth factor-23 and reagent therefor
|
|
WO2012055096A1
(zh)
*
|
2010-10-27 |
2012-05-03 |
温州医学院生物与天然药物开发中心有限公司 |
抗fgf-23抗体的制备方法及用途
|
|
US20140294820A1
(en)
|
2011-06-24 |
2014-10-02 |
University Of Miami |
Fibroblast growth factor receptor inhibition for the treatment of disease
|
|
US8951966B2
(en)
|
2011-07-01 |
2015-02-10 |
Ngm Biopharmaceuticals, Inc. |
Compositions comprising variants and fusions of FGF19 polypeptides, and uses and methods thereof for treatment of metabolic disorders and diseases
|
|
WO2013027191A1
(en)
|
2011-08-25 |
2013-02-28 |
Novartis Ag |
Methods and compositions using fgf23 fusion polypeptides
|
|
US9657075B2
(en)
|
2012-06-07 |
2017-05-23 |
New York University |
Chimeric fibroblast growth factor 23 proteins and methods of use
|
|
US9290557B2
(en)
|
2012-11-28 |
2016-03-22 |
Ngm Biopharmaceuticals, Inc. |
Compositions comprising variants and fusions of FGF19 polypeptides
|
|
EP3798228A1
(en)
|
2012-11-28 |
2021-03-31 |
NGM Biopharmaceuticals, Inc. |
Compositions and methods for treatment of metabolic disorders and diseases
|
|
US9273107B2
(en)
|
2012-12-27 |
2016-03-01 |
Ngm Biopharmaceuticals, Inc. |
Uses and methods for modulating bile acid homeostasis and treatment of bile acid disorders and diseases
|
|
MX383664B
(es)
|
2012-12-27 |
2025-03-14 |
Ngm Biopharmaceuticals Inc |
Uso de un péptido para modular la homeostasis de los ácidos biliares o tratamiento de una enfermedad relacionada con los ácidos biliares.
|
|
WO2014130659A1
(en)
|
2013-02-22 |
2014-08-28 |
New York University |
Chimeric fibroblast growth factor 23 proteins and methods of use
|
|
CN111269874B
(zh)
*
|
2013-09-20 |
2024-04-26 |
隆萨有限公司 |
细胞的核重编程的方法
|
|
NZ718962A
(en)
|
2013-10-28 |
2019-12-20 |
Ngm Biopharmaceuticals Inc |
Cancer models and associated methods
|
|
RS60593B1
(sr)
|
2014-01-24 |
2020-08-31 |
Ngm Biopharmaceuticals Inc |
Antitela koja vezuju domen 2 beta-kloto i postupci za njihovu upotrebu
|
|
CN106456714A
(zh)
|
2014-03-28 |
2017-02-22 |
纽约大学 |
Fgf23融合蛋白
|
|
US10398758B2
(en)
|
2014-05-28 |
2019-09-03 |
Ngm Biopharmaceuticals, Inc. |
Compositions comprising variants of FGF19 polypeptides and uses thereof for the treatment of hyperglycemic conditions
|
|
DK3845245T3
(da)
|
2014-06-09 |
2025-09-15 |
Ultragenyx Pharmaceutical Inc |
Effektiv og virkningsfuld kontrol af serumphosphat til optimal knogledannelse
|
|
EP3155005A4
(en)
|
2014-06-16 |
2018-07-11 |
NGM Biopharmaceuticals, Inc. |
Methods and uses for modulating bile acid homeostasis and treatment of bile acid disorders and diseases
|
|
SG11201702757YA
(en)
|
2014-10-23 |
2017-05-30 |
Ngm Biopharmaceuticals Inc |
Pharmaceutical compositions comprising peptide variants and methods of use thereof
|
|
US10434144B2
(en)
|
2014-11-07 |
2019-10-08 |
Ngm Biopharmaceuticals, Inc. |
Methods for treatment of bile acid-related disorders and prediction of clinical sensitivity to treatment of bile acid-related disorders
|
|
CA2969307A1
(en)
|
2014-12-04 |
2016-06-09 |
Novartis Ag |
Methods and compositions using klotho variant polypeptides
|
|
CN105699664A
(zh)
*
|
2015-04-13 |
2016-06-22 |
陈柏龄 |
Fgf23检测试剂盒及其制备方法
|
|
WO2016210350A1
(en)
|
2015-06-25 |
2016-12-29 |
Amyris, Inc. |
Maltose dependent degrons, maltose-responsive promoters, stabilization constructs, and their use in production of non-catabolic compounds
|
|
US10800843B2
(en)
|
2015-07-29 |
2020-10-13 |
Ngm Biopharmaceuticals, Inc. |
Beta klotho-binding proteins
|
|
JP6728352B2
(ja)
|
2015-11-09 |
2020-07-22 |
エヌジーエム バイオファーマシューティカルス，インコーポレーテッド |
胆汁酸に関係した障害の治療方法
|
|
US11370841B2
(en)
|
2016-08-26 |
2022-06-28 |
Ngm Biopharmaceuticals, Inc. |
Methods of treating fibroblast growth factor 19-mediated cancers and tumors
|
|
EP3604503B1
(en)
*
|
2017-03-28 |
2026-03-18 |
Ajinomoto Co., Inc. |
Additive for undifferentiation maintaining medium
|
|
US12498366B2
(en)
|
2017-05-31 |
2025-12-16 |
Canon Medical Diagnostics Corporation |
Measurement method for fibroblast growth factor-23 by forming immunocomplexes
|
|
WO2020047475A1
(en)
*
|
2018-08-30 |
2020-03-05 |
The Uab Research Foundation |
Drug screening for fgf23-fgfr4 inhibitors
|
|
PH12021552414A1
(en)
*
|
2019-03-29 |
2022-07-25 |
Atarga Llc |
Anti fgf23 antibody
|
|
EP3956354A1
(en)
*
|
2019-04-19 |
2022-02-23 |
Genethon |
Gene therapy of fibroblast growth factor 23 related hypophosphatemic diseases
|
|
KR102987382B1
(ko)
*
|
2020-11-27 |
2026-07-03 |
한국해양과학기술원 |
Fgf11 동형2 폴리펩타이드 및 그 용도
|